AnaCardio
Developer of therapeutic drugs designed to improve clinical outcomes in cardiac failure. The company's drugs improve the contractility of the heart muscle through a differentiated mechanism using a th...
Valuation
$0
Share Price
N/A
Total Raised
$44.2M
Last Round
N/A